Explorative Analyses on the Value of Interim PET for Prediction of Response in Pediatric and Adolescent Non-Hodgkin Lymphoma Patients

EJNMMI Research - Germany
doi 10.1186/2191-219x-3-71
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

On the Prediction of Hodgkin Lymphoma Treatment Response

Clinical and Translational Oncology
MedicineCancer ResearchOncology
2015English

Interim FDG-PET Has No Value in Selecting Patients Who Require Treatment Modification in Both Early- And Advanced-Stage Hodgkin Lymphoma

British Journal of Haematology
Hematology
2017English

Interim FDG-PET Has No Value in Selecting Patients Who Require Treatment Modification in Both Early- And Advanced-Stage Hodgkin Lymphoma: Response to Adams and Kwee

British Journal of Haematology
Hematology
2017English

Prognostic Value of Pre-Transplant Pet/Ct in Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Fluorine-18 Fluorodeoxyglucose PET-CT for Extranodal Staging of Non-Hodgkin and Hodgkin Lymphoma

Diagnostic and Interventional Radiology
Nuclear MedicineRadiologyCardiovascular MedicineImagingCardiology
2014English

Interim FDG-PET Does Not Predict Outcome in Advanced-Stage Hodgkin Lymphoma Patients Treated With BEACOPP

British Journal of Haematology
Hematology
2018English

Quantitative Assessment of Interim PET in Hodgkin Lymphoma: An Evaluation of the qPET Method in Adult Patients in the RAPID Trial

PLoS ONE
Multidisciplinary
2020English

Hodgkin Lymphoma: Is There Really a Need for Interim and End-Of-Treatment FDG-PET Evaluations?

British Journal of Haematology
Hematology
2016English

Interim FDG-PET/CT in Hodgkin Lymphoma: What Are We Actually Looking At?

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy